Q0224 Injection, pemivibart, 4500 milligrams
Q-Codes
Also known as: Synagis, palivizumab, RSV prophylaxis
Pemivibart injection 4500 milligram formulation, a monoclonal antibody used for respiratory syncytial virus prophylaxis in high-risk patients.
Clinical Context
Used for passive immunoprophylaxis against respiratory syncytial virus in high-risk infants including premature infants and those with congenital heart disease. Given monthly during RSV season.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.